XERIS BIOPHARMA HOLDINGS INC's ticker is and the CUSIP is 98422E103. A total of 93 filers reported holding XERIS BIOPHARMA HOLDINGS INC in Q1 2023. The put-call ratio across all filers is 0.17 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $528,972 | -28.3% | 284,392 | +1.0% | 0.03% | -28.9% |
Q2 2023 | $737,379 | +60.7% | 281,442 | 0.0% | 0.04% | +46.2% |
Q1 2023 | $458,762 | +16.2% | 281,442 | -5.2% | 0.03% | +4.0% |
Q4 2022 | $394,833 | -24.5% | 296,867 | -11.5% | 0.02% | -37.5% |
Q3 2022 | $523,000 | +0.6% | 335,287 | -0.6% | 0.04% | -13.0% |
Q2 2022 | $520,000 | -48.3% | 337,387 | -1.6% | 0.05% | -37.8% |
Q4 2021 | $1,005,000 | – | 342,897 | – | 0.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CAXTON CORP | 5,641,920 | $14,781,830 | 42.66% |
Stonepine Capital Management, LLC | 5,500,228 | $14,410,597 | 5.20% |
MPM BioImpact LLC | 3,974,999 | $10,414,497 | 2.10% |
Soleus Capital Management, L.P. | 2,054,105 | $5,381,755 | 0.60% |
EAM Investors, LLC | 757,962 | $1,985,860 | 0.37% |
DELTEC ASSET MANAGEMENT LLC | 406,190 | $1,064,218 | 0.23% |
Alpine Global Management, LLC | 225,000 | $589,500 | 0.18% |
Redmile Group, LLC | 1,046,587 | $2,742,058 | 0.10% |
IHT Wealth Management, LLC | 281,442 | $737,379 | 0.04% |
OCCUDO QUANTITATIVE STRATEGIES LP | 127,091 | $332,978 | 0.04% |